Divergent Patterns of MSH3 Expression and EMAST in Non-Small Cell Lung Cancer
Genes · 16.11.2026 · 17 (11) · 1445
DOI: 10.3390/genes17111445 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 16.11.2026. Verfasst von Hannah W. Parker und 6 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Commonwealth through an Australian Government Research Training Program Scholarship.
Abstract (Originalsprache)
Background/Objectives: Elevated microsatellite alterations at selected tetranucleotide repeats (EMAST) represent a distinct form of genomic instability linked to MSH3 deficiency or dysfunction in colorectal cancer. However, the molecular basis underlying EMAST in lung cancer remains poorly understood, although an association with TP53 mutations has been reported. Here, we investigated the relationship between EMAST and MSH3 expression in non-small cell lung cancer (NSCLC).
Methods
A PCR panel targeting ten tetranucleotide microsatellite loci was developed and analysed by capillary electrophoresis. MSH3 protein expression was evaluated by immunohistochemistry in corresponding tumour specimens. To explore the genomic context of MSH3 alterations, data from 1053 NSCLC cases in The Cancer Genome Atlas (TCGA) were analysed for TP53 mutations, MSH3 copy number alterations, and MSH3 mRNA expression.
Results
EMAST was defined as instability at ≥1 of the 10 tetranucleotide markers and was significantly more frequent in lung squamous cell carcinoma (LUSC) than in lung adenocarcinoma (LUAD) (50% vs. 16%, p < 0.0001). Notably, approximately half of all EMAST events involved the L17686/D7S1482 locus, indicating that this repeat is particularly susceptible to genomic instability in lung cancer. Complete loss of MSH3 protein expression was not observed. Instead, patches of heterogeneous mosaic staining, with intermixed MSH3-positive and MSH3-negative tumour cells, were observed in 28% of cases but were not associated with EMAST. This suggests that there may be additional causes of EMAST generation in lung cancer. Consistent with this, TCGA analyses demonstrated a strong association between TP53 mutation and MSH3 copy number loss, with both alterations occurring significantly more frequently in LUSC than in LUAD.
Conclusions
EMAST is a common and readily detectable form of genomic instability in NSCLC using PCR. The marked enrichment of instability at the L17686/D7S1482 locus is consistent with a model in which TP53-driven replication stress contributes to locus-specific tetranucleotide repeat instability in lung cancer alongside compromised MSH3-related DNA repair. These findings provide new insights into EMAST generation and establish a platform for investigating its biological significance in NSCLC.
Förderung
- Commonwealth through an Australian Government Research Training Program Scholarship
Zitieren
APA
Parker, H. W., Berry, M. A., Jahan, Z., Cheung, V. K. Y., Cooper, W. A., Oliver, B. G. G., & Kohonen-Corish, M. R. J. (2026). Divergent Patterns of MSH3 Expression and EMAST in Non-Small Cell Lung Cancer. Genes, 17(11), 1445. https://doi.org/10.3390/genes17111445
Vancouver
Parker HW, Berry MA, Jahan Z, Cheung VKY, Cooper WA, Oliver BGG, et al. Divergent Patterns of MSH3 Expression and EMAST in Non-Small Cell Lung Cancer. Genes. 2026;17(11):1445. doi:10.3390/genes17111445
BibTeX
@article{Parker2026,
author = {Parker, Hannah W. and Berry, Madeleine A. and Jahan, Zeenat and Cheung, Veronica K. Y. and Cooper, Wendy A. and Oliver, Brian G. G. and Kohonen-Corish, Maija R. J.},
title = {Divergent Patterns of MSH3 Expression and EMAST in Non-Small Cell Lung Cancer},
journal = {Genes},
year = {2026},
volume = {17},
number = {11},
pages = {1445},
doi = {10.3390/genes17111445}
}
EUVIMED